|
시장보고서
상품코드
2032380
임상 데이터 분석 시장 보고서 : 솔루션별, 도입 형태별, 용도별, 최종 사용자별, 지역별(2026-2034년)Clinical Data Analytics Market Report by Solution, Deployment Mode, Application, End User, and Region 2026-2034 |
||||||
세계의 임상 데이터 분석 시장 규모는 2025년에 342억 달러에 이르렀습니다. 향후 IMARC Group은 2034년까지 시장 규모가 3,561억 달러에 이르고, 2026-2034년 CAGR은 28.83%를 나타낼 것으로 예측했습니다.
임상 데이터 분석은 정형 및 비정형 의료 데이터를 실시간으로 하나의 표준화된 에코시스템으로 변환합니다. 이는 고급 머신러닝(ML) 분석을 활용하여 예측 가능한 인사이트와 숨겨진 지식을 도출하는 것입니다. 이를 통해 의료진이 정보에 입각한 의사결정을 내릴 수 있도록 돕고, 임상적 의사결정 지원을 제공하며, 지역 주민의 건강 상태 개선, 진료 연계 강화, 환자 건강 증진에 기여합니다. 그 결과, 환자 결과, 지역 주민의 건강, 임상 품질 등 의료 시스템의 성과와 관련된 다양한 측면에 대한 데이터를 얻기 위해 전 세계 의료기관에서 널리 채택하고 있습니다. 또한, 투약 오류 감소, 관리 비용 최소화, 수익 증대에도 기여합니다.
임상 데이터 분석 시장 동향 :
의료관리의 급속한 디지털화에 따라 전자건강기록(EHR)의 활용이 증가하면서 방대한 양의 임상 데이터가 생성되고 있습니다. 이는 정보를 효율화하고 인적 오류를 최소화하기 위해 임상 데이터 분석이 필요한 주요 요인 중 하나입니다. 또한, 코로나19가 전 세계 의료 인프라에 큰 영향을 미치면서 환자 치료의 연계 개선과 실시간 정보 접근에 있어 EHR 솔루션의 활용도가 높아지고 있는 것도 이러한 추세의 한 요인으로 작용하고 있습니다. 여기에 m-헬스 앱의 등장과 병원의 질 높은 맞춤형 의료에 대한 관심이 높아지면서 시장 성장에 기여하고 있습니다. 또한, 많은 의료기관들이 변화하는 정부 규제에 대응하고, 의료비를 절감하며, 전반적인 환자 치료의 질을 향상시키기 위해 임상 데이터 분석을 도입하고 있습니다. 또한, 만성질환의 유병률 증가에 따라 신약 임상시험에 대한 투자가 증가하고 있는 것도 세계 임상 데이터 분석 수요에 긍정적인 영향을 미칠 것으로 예측됩니다.
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 주요 요약
제4장 서론
제5장 세계의 임상 데이터 분석 시장
제6장 시장 분석 : 솔루션별
제7장 시장 분석 : 도입 모드별
제8장 시장 분석 : 용도별
제9장 시장 분석 : 최종 사용자별
제10장 시장 분석 : 지역별
제11장 SWOT 분석
제12장 밸류체인 분석
제13장 Porter's Five Forces 분석
제14장 가격 분석
제15장 경쟁 구도
KTH 26.05.15The global clinical data analytics market size reached USD 34.2 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 356.1 Billion by 2034, exhibiting a growth rate (CAGR) of 28.83% during 2026-2034.
Clinical data analytics transforms structured and unstructured medical data into a single, standardized ecosystem in real-time. It relies on sophisticated machine learning (ML) analysis to generate predictive and hidden insights. It assists healthcare providers in making informed decisions, providing clinical decision support, improving population health, enhancing care coordination, and improving patient wellness. As a result, it is widely adopted by health organizations across the globe to retrieve data concerning different aspects of health system performance, such as patient outcomes, population health, and clinical quality. Besides this, it can help reduce medication errors, minimize administrative costs, and increase revenues.
CLINICAL DATA ANALYTICS MARKET TRENDS:
The increasing usage of electronic health records (EHRs) on account of rapid digitization in healthcare management has led to vast amounts of clinical data. This represents one of the key factors driving the need for clinical data analytics to streamline information and minimize human errors. This can also be attributed to the increasing application of EHR solutions in improving patient care coordination and accessing information in real-time due to a significant impact of coronavirus disease (COVID-19) on healthcare infrastructure worldwide. Apart from this, the emergence of m-health apps, in confluence with the increasing emphasis on high-quality personalized care in hospitals, is contributing to the market growth. Moreover, several health organizations are integrating clinical data analytics to address the challenges of changing governmental regulations while lowering healthcare costs and improving the overall quality of patient care. Besides this, rising investments in clinical studies of new drugs due to the growing prevalence of chronic diseases are anticipated to positively influence the demand for clinical data analytics across the globe.
KEY MARKET SEGMENTATION:
Breakup by Solution:
- Software
- Services
Breakup by Deployment Mode:
- Cloud-based
- On-premises
Breakup by Application:
- Quality Improvement and Clinical Benchmarking
- Clinical Decision Support
- Regulatory Reporting and Compliance
- Comparative Analytics
- Precision Health
Breakup by End User:
- Pharmaceutical Companies
- Healthcare Organizations
- Research Organizations
- Government Organizations
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
COMPETITIVE LANDSCAPE:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Allscripts Healthcare Solutions Inc., CareEvolution LLC, Cerner Corporation, Health Catalyst, International Business Machines Corporation, InterSystems Corporation, Koninklijke Philips N.V., Medeanalytics Inc., Sisense Inc., UnitedHealth Group Incorporated and Xerox Holdings Corporation.
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Clinical Data Analytics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Solution
- 6.1 Software
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Services
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Deployment Mode
- 7.1 Cloud-based
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 On-premises
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Application
- 8.1 Quality Improvement and Clinical Benchmarking
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Clinical Decision Support
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Regulatory Reporting and Compliance
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Comparative Analytics
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Precision Health
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
9 Market Breakup by End User
- 9.1 Pharmaceutical Companies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Healthcare Organizations
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Research Organizations
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Government Organizations
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Allscripts Healthcare Solutions Inc.
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 CareEvolution LLC
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 Cerner Corporation
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 Health Catalyst
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.5 International Business Machines Corporation
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 InterSystems Corporation
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 SWOT Analysis
- 15.3.7 Koninklijke Philips N.V.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Medeanalytics Inc.
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.9 Sisense Inc.
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.10 UnitedHealth Group Incorporated
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 Xerox Holdings Corporation
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis
- 15.3.1 Allscripts Healthcare Solutions Inc.
